Bio-Rad Laboratories, Inc. (BIO)

Life science and diagnostics products maker. Read October 19, 2026 from the annual report for the period ending December 31, 2025, filed February 13, 2026. Ranked 56 of the 104 Healthcare companies read so far, by the share within reach now.

A life science company whose filing states 7,450 employees with 3,068 in the U.S. and nothing by product, so reagents and instruments are read evenly by description.

The figures on this page come from the company's own annual report and from BLS staffing patterns for its industries, never from a roster. They are estimates with a stated method. Nothing here says what the company will do: within reach is not a forecast of jobs lost or of savings.

What follows from the reading

Share of working time within reach of AI, on the long-run pace at four in five: 19% now, 36% at the end of 2027, 45% at the end of 2028, 49% at the end of 2030. By the patterns, the work is about 49% desk work, 16% people work and 35% body work. These are the site's industry estimates weighted by the shares below: estimates with a stated method and range, not a forecast of what the company will do. By the same patterns, at the end of 2028 about 51% of the working time stays with people (conversation, in-person and hands-on work), 40% becomes checking a model's work and 5% could be handed over with lighter checks, from the industries' own figures, not the company's roles.

Headcount

7,450 employees as of December 31, 2025 (stated). Stated by count: approximately 3,068 U.S. employees of 7,450; roughly 46% in the Americas, 36% in Europe, the Middle East and Africa, 18% in Asia Pacific.

The filing: “At December 31, 2025, we had approximately 7,450 employees, the overwhelming majority of which are full-time employees.”

The workforce as industry patterns

What the filing says about the workforce: Approximately 7,450 employees at December 31, 2025 (7,700 a year earlier), the overwhelming majority full-time, in 37 countries: roughly 46% in the Americas, 36% in EMEA, 18% in Asia Pacific; about 6% of the 3,068 U.S. employees under a collective bargaining agreement.

Companies read with the same leading pattern

Other companies whose largest staffing pattern is also Pharmaceutical and Medicine Manufacturing, largest first, each read from its own annual report. Within reach now and at the end of 2028, long-run pace, four in five.

• Johnson & Johnson (JNJ, 140,800 employees)19% now, 39% by 2028
• Thermo Fisher Scientific Inc. (TMO, 125,000 employees)20% now, 49% by 2028
• Merck & Co., Inc. (MRK, 75,000 employees)19% now, 41% by 2028
• Pfizer Inc. (PFE, 75,000 employees)19% now, 41% by 2028
• AbbVie Inc. (ABBV, 57,000 employees)19% now, 41% by 2028
• Eli Lilly and Company (LLY, 50,000 employees)19% now, 41% by 2028
• Bristol-Myers Squibb Company (BMY, 32,500 employees)19% now, 41% by 2028
• Amgen Inc. (AMGN, 31,500 employees)19% now, 41% by 2028

What the filing says about AI

8 sentences in the filing name AI. The filing says it uses AI and machine learning technologies such as chatbots, assistants and automation agents in its operations and is exploring other opportunities, while generative AI and its regulation pose risks.

• “Use of generative AI and other AI technologies presents risks and challenges due to the evolving nature of AI.”
• “We utilize artificial intelligence and machine learning technologies ("AI"), such as chatbots, assistants and automation agents, in our business operations, and we are exploring the other opportunities that AI could bring us.”
• “The use of AI, particularly generative AI, and the developing regulatory landscape pose risks that could expose us to liability or adversely affect our business.”
• “Integration of AI into our and our vendors' systems (potentially without the vendor disclosing such use to us) subjects us to the risk that the providers of AI may not meet existing or rapidly evolving regulatory or industry standards with respect to privacy and data protection.”
• “Sophisticated cyberattacks, including those using AI, could increase these risks.”

Its annual reports, year by year

Sentences naming AI in each annual report, counted by one rule, beside the median report in the Index that year. Each count links its filing. Every company, by year and sector

• Fiscal 20210median 0
• Fiscal 20220median 0
• Fiscal 20230median 1
• Fiscal 20248median 4
• Fiscal 20258median 10

Headcount by filing year

As reported in each year's annual report, with the filing. A year marked not read had no figure the reading could take from the report's text.

Limits of this reading

• No count by product: the split between reagents and instruments is by description (c).

Source: the company's annual report on EDGAR, accession 0000012208-26-000010, the filing. Read by Claude Fable 5.1 under rubric version 1, by the method. A company can write to info@stratussc.com to have its reading checked against its filing.